Vultr's Kevin Cochrane and AMD's Aleks Shargorodskiy discuss their partnership and managing global cloud infrastructure at ...
Investor's Business Daily on MSN
ACADIA Pharmaceuticals Scores Relative Strength Rating Upgrade; Hits Key Benchmark
On Wednesday, ACADIA Pharmaceuticals ACAD received an upgrade to its Relative Strength (RS) Rating, from 67 to 80. This ...
Investor's Business Daily on MSN
Exelixis Hits 80-Plus Relative Strength Rating Benchmark
Exelixis shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 81.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback